Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05359250 · ClinicalTrials.gov registry record
Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 10
- Enrollment target
NCT05359250: Completed study, sponsored by University of Colorado, Denver.
NCT05359250 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05359250 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The overall goal of the study is to investigate the characteristics and potential mechanisms responsible for myocardial injury and dysfunction in patients after COVID-19 vaccination. Cardiac damage will be assessed with cardiac MRI and endomyocardial biopsy (EmBx) histopathology. Myocardial gene expression will be measured in RNA extracted from EmBxs mRNA abundance compared to nonfailing and failing control hearts.
Primary Outcome
Initial clinical diagnosis of myocardial injury or myocarditis will be confirmed by cardiac MRI. Specific findings of late gadolinium enhancement and abnormal T1-signals within the myocardium consistent with acute injury, inflammation or edema will be evaluated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-05-12 |
| Est. Completion | 2024-12-30 |
What the finished NCT05359250 record still lists
NCT05359250 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05359250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05359250 about?
NCT05359250 is a clinical study titled "Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination". The overall goal of the study is to investigate the characteristics and potential mechanisms responsible for myocardial injury and dysfunction in patients after COVID-19 vaccination. Cardiac damage will be assessed with cardiac MRI and endomyocardial biopsy (EmBx) histopathology. Myocardial gene exp...
What is the current status of trial NCT05359250?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2021-05-12. Estimated completion is 2024-12-30.
Who is sponsoring clinical trial NCT05359250?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI